Debut Plus

₹64.46

▲ +1.93 +3.09%

As of 23 Oct 2026 · delayed

NSE Listed

Shukra Pharmaceuticals Limited (SHUKRAPHAR)

Volume: 21,38,303Avg Vol 1W: 8,44,040Avg Vol 1M: 7,72,85452W Range:₹40.06₹75.4
NSE BSE www.shukrapharmaceuticals.com AI Report
Key Ratios
Checked 5h ago
Market Cap₹2,852 Cr
Current Price₹64.46
Previous Close₹62.53
High / Low (52w)₹75.4 / ₹40.06
Volume21,38,303
Avg Vol (1W)8,44,040
Avg Vol (1M)7,72,854
Stock P/E83.71
Book Value₹2.28
Dividend Yield2%
ROE24.55%
ROA28.93%
Revenue (TTM)—
Revenue Growth—
Profit Margin45.4%
Total Debt—
Shares Outstanding44 Cr
Face Value—
EPS (TTM)₹0.77
P/B28.25
Debt / Equity0.06
50 DMA₹55.19
200 DMA₹40.87
Day change+3.09%
Price Chart
₹64.46▲ 56.95% · 1Y
₹73₹2736.5L
2025-10-27
2026-10-23

20-day avg volume: 8.1L shares

Pros
  • Healthy return on equity of 24.6%.
  • Pays a dividend yield of 2.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 62% YoY.
  • Stock trades at a high P/E of 84.
Quarterly Results
MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹11 Cr₹13 Cr₹5 Cr₹6 Cr₹39 Cr₹6 Cr₹24 Cr
EBITDA₹4 Cr₹8 Cr₹2 Cr₹0 Cr₹27 Cr₹1 Cr₹19 Cr
Net Profit₹3 Cr₹5 Cr₹1 Cr₹2 Cr₹20 Cr₹-2 Cr₹13 Cr
EPS———————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹37 Cr₹13 Cr₹5 Cr₹6 Cr₹39 Cr₹61 Cr₹6 Cr₹24 Cr
EBITDA₹14 Cr₹8 Cr₹2 Cr₹0 Cr₹27 Cr₹30 Cr₹1 Cr₹21 Cr
Net Profit₹10 Cr₹5 Cr₹1 Cr₹2 Cr₹20 Cr₹22 Cr₹-2 Cr₹15 Cr
EPS0.22————0.5——
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹28 Cr₹34 Cr₹36 Cr₹35 Cr₹75 Cr₹78 Cr₹87 Cr₹117 Cr
Total Liabilities₹13 Cr₹18 Cr₹20 Cr₹19 Cr₹50 Cr₹20 Cr₹24 Cr₹28 Cr
Equity₹15 Cr₹15 Cr₹16 Cr₹16 Cr₹25 Cr₹58 Cr₹63 Cr₹90 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹1 Cr₹8 Cr₹3 Cr₹-5 Cr₹12 Cr₹5 Cr
Investing₹-2 Cr₹-2 Cr₹-4 Cr₹-1 Cr₹-1 Cr₹-14 Cr
Financing₹2 Cr₹-7 Cr₹5 Cr₹12 Cr₹-5 Cr₹5 Cr
Free Cash Flow₹1 Cr₹8 Cr₹3 Cr₹-5 Cr₹12 Cr₹5 Cr
Shareholding
Promoter 51.15% Institutions 0.65% Public 48.2%
Efficiency & Working Capital
ROCE31.5%
Interest Coverage26
Dividend Payout—
Debtor Days148 d
Inventory Days89 d
Payable Days65 d
Cash Conversion Cycle172 d
Working Capital Days237 d
Shareholding Details

As of 2026-09-30

Promoter51.2%
FII0.4%
DII0.2%
Institutions0.7%
Public48.2%
Promoter Pledge0%
No. of Shareholders35,007
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Aug 2026Sept 2026
Promoters51%51%51%51%51%51%51%51%51%51%51.2%51.2%
FIIs0%0%0%0%0%0%0%0%0%0%0%0.4%
DIIs0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.2%
Public48.9%48.9%48.9%48.9%48.9%48.9%48.9%48.9%48.9%48.9%48.7%48.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders12,97414,98916,32117,84418,23120,33721,44125,64927,17328,38428,38435,007
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Renuka Yogesh ParikhPublic Shareholding19.1%8.40 Cr
Anar Project Private LimitedShareholding of Promoter and Promoter Group18.7%8.22 Cr
Yogesh Biharilal ParikhPublic Shareholding17.6%7.72 Cr
Parshva Texchem India Private Ltd.Shareholding of Promoter and Promoter Group17.4%7.64 Cr
Navkar Surgical GujaratShareholding of Promoter and Promoter Group11.7%5.16 Cr
Dakshesh Rameshchandra ShahShareholding of Promoter and Promoter Group1.1%48,60,000
Anar Jayeshbhai PatelShareholding of Promoter and Promoter Group1%43,60,000
Sujay Jyotindra MehtaShareholding of Promoter and Promoter Group0.7%31,20,000
Payal Sujay MehtaShareholding of Promoter and Promoter Group0.5%22,80,000
Board of Directors
NameDesignationYear
Dakshesh ShahChairman / Executive Director / Managing Director2025
Payal MehtaExecutive Director2025
Dhruvin ShahE D & Wholetime Director2025
Sanskruti PatelE D & Wholetime Director2025
Pinki Nirmal SagarIndependent Non Exe. Director2025
Sonal Deepalbhai GandhiIndependent Non Exe. Director2025
Sarjeevan SinghIndependent Non Exe. Director2025
Jitendra shahIndependent Non Exe. Director2025
Anar Jayesh PatelExecutive Director / Whole Time Director / CFO2025
SHITAL DAKSHESH SHAHE D & Wholetime Director2025
Ritu KapoorIndependent Non Exe. Director2025
Shivkant DhakadCompany Secretary / Compliance Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1494444
Corporate Actions
TypeDateValueRemark
forthcoming2026-09-21Dividend—
dividend2026-09-21₹0.01 (1%)Final
forthcoming2026-08-12Board Meetings—
forthcoming2026-08-11Board Meetings—
dividend2025-09-18₹0.01 (1%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000505
2026000404
2026000101
Company Information
Incorporated1993
ChairmanDakshesh Shah
AuditorMAAK & Associates
Investor Email[email protected]
🌐 www.shukrapharmaceuticals.com ↗

📍 3 rd Floor Dev House, Opp WIAA Office Judges Bungalo, Ahmedabad, Gujarat, 380054

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Shriram Finance LimitedShriram Properties Ltd.Shri Techtex LimitedShri Jagdamba Polymers LimitedShubhlaxmi Jewel Art Ltd.Shubhshree Biofuels Ene LimitedShyam Century FerrousShyam Dhani Industries LimitedShyam Metalics And Engy LimitedShyam Telecom LimitedSicagen India LimitedSical Logistics LimitedAll “S” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search